MedTrace Logo

Wound Treatment With 3% Sodium Pentaborate Pentahydrate

NCT02241811 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-01-15

No results posted yet for this study

Summary

Chronic foot wounds which is very difficult to treat are common especially in diabetic and peripheral arterial or venous insufficiency patients. This research is aim to observe the foot wound's recovery with 3% Sodium pentaborate pentahydrate hydrogel.

Conditions

  • Wound Healing

Interventions

DRUG

3% Sodium Pentaborate Pentahydrate

For the interventional group after wound dressing we applied hydrogel with 3% Sodium pentaborate pentahydrate everyday for two months. The same doctor observed and took photo of the wounds every week in the outpatients clinic.

DRUG

Placebo

Hydrogel without 3% Sodium Pentaborate Pentahydrate

Sponsors & Collaborators

  • Bezmialem Vakif University

    collaborator OTHER

  • SB Istanbul Education and Research Hospital

    lead OTHER

Principal Investigators

  • Erhan Aysan, MD Prof. · Bezmialem Vakif University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2021-12-31
Completion
2023-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02241811 on ClinicalTrials.gov